Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial Dysfunction
Stopped We were unable to recruit any subjects into this study so no subjects completed the protocol. Therefore, we are unable to provide any conclusions.
Conditions
- Isolated Systolic Hypertension
- Endothelial Dysfunction
Interventions
- DRUG: 6R-BH4
- OTHER: Placebo
Sponsor
Johns Hopkins University
Collaborators